Search Results

8,511 Results for "abbott".

Sort By

Press Releases

Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease

March 24, 2025
·
4 min read
Press Releases

Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

March 28, 2025
·
6 min read
Press Releases

Cadrenal Therapeutics Announces Collaboration Agreement with Abbott in Support of Pivotal Study of Tecarfarin in Patients with HeartMate 3™ LVAD

March 4, 2025
·
5 min read
Press Releases

Abbott’s ‘Above the Bias’ Film Reveals Misconceptions Can Impact Diabetes Care

February 4, 2025
·
5 min read
Press Releases

Abbott Hosts Conference Call for Fourth-Quarter Earnings

January 2, 2025
·
1 min read
Business

Abbott Hosts Conference Call for Second-Quarter Earnings - June 27, 2024

Abbott (NYSE: ABT) will announce its second-quarter 2024 financial results on Thursday, July 18, before the market opens.

June 27, 2024
·
1 min read
Press Releases

Abbott Increases Quarterly Dividend for 53rd Consecutive Year

December 16, 2024
·
1 min read
Press Releases

Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook

January 22, 2025
·
28 min read
Job Trends

Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems

Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose monitoring (CGM) systems – Lingo™ and Libre Rio™, which are based on Abbott’s world-leading FreeStyle Libre® continuous glucose monitoring technology1, now used by about 6 million people globally2.

June 10, 2024
·
7 min read
Press Releases

Beta Bionics Announces Launch of the iLet Bionic Pancreas With Abbott’s FreeStyle Libre 3 Plus Sensor

October 30, 2024
·
2 min read